ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment [Anatol J Cardiol]
Anatol J Cardiol. 2010; 10(Suppl 1): 36-42 | DOI: 10.5152/akd.2010.117

Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment

Mehmet Mustafa Can, Cihangir Kaymaz
Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, İstanbul, Türkiye


Mehmet Mustafa Can, Cihangir Kaymaz. Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment. Anatol J Cardiol. 2010; 10(Suppl 1): 36-42

Corresponding Author: Cihangir Kaymaz, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.